机构：[1]Postgraduate Training Base Alliance of Wenzhou Medical University (Zhejiang Cancer Hospital), Hangzhou, 310022, Zhejiang, China.浙江省肿瘤医院[2]Traditional Chinese Medicine Pharmacy, Zhejiang Hospital, Hangzhou, 310022, Zhejiang, China.[3]Department of Pain, First Affiliated Hospital of Kunming Medical University, Yunnan, 650000, China.昆明医科大学附属第一医院[4]Department of Anesthesiology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, China. ywf808@yeah.net.[5]Department of Anesthesiology, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, 310022, Zhejiang, China. xiekj9261@126.com.浙江省肿瘤医院[6]Department of Anesthesiology, The People's Hospital of Qiannan, Duyun, 558000, China. xiekj9261@126.com.
第一作者机构：[1]Postgraduate Training Base Alliance of Wenzhou Medical University (Zhejiang Cancer Hospital), Hangzhou, 310022, Zhejiang, China.
推荐引用方式(GB/T 7714)：
Gu Fulei,Zhou Yuxuan,Tian Lili,et al.Author Correction: Morphine promotes non-small cell lung cancer progression by downregulating E-cadherin via the PI3K/AKT/mTOR pathway[J].Scientific Reports.2025,15(1):36284.doi:10.1038/s41598-025-23902-2.
APA：
Gu Fulei,Zhou Yuxuan,Tian Lili,Chen Jinyan,Zhang Can...&Xie Kangjie.(2025).Author Correction: Morphine promotes non-small cell lung cancer progression by downregulating E-cadherin via the PI3K/AKT/mTOR pathway.Scientific Reports,15,(1)
MLA：
Gu Fulei,et al."Author Correction: Morphine promotes non-small cell lung cancer progression by downregulating E-cadherin via the PI3K/AKT/mTOR pathway".Scientific Reports 15..1(2025):36284
